Clinical trials · Pittsburgh, PA
Urinary Bladder Neoplasms clinical trials in Pittsburgh
We’re tracking 3 recruiting urinary bladder neoplasms studies with a site in or near Pittsburgh — including Early Phase 1, Phase 1 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies near Pittsburgh
- NCT05614739RecruitingPhase 1
Study of vepugratinib for cancers with FGFR3 gene changes
This study tests a new pill, vepugratinib, for people whose cancer has a specific change in a gene called FGFR3. The drug targets this gene change to try to slow or shrink the cancer, and may be an option if standard treatments have not worked.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT07218380RecruitingPhase 3
Study of Vepugratinib for advanced bladder or urinary tract cancer
This trial tests an experimental drug called Vepugratinib for people with advanced urinary tract cancer that has a specific change in the FGFR3 gene. It may be an option if you haven't had other treatments for advanced cancer and are looking for a new approach.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT04369560RecruitingEarly Phase 1
Virtual MRI to map bladder cancer for staging before surgery
This early-stage study uses special MRI imaging to create a “virtual view” of the bladder wall so doctors can better stage bladder cancer before treatment. If you qualify, you may get MRI imaging using contrast medicines as part of planning your surgery.
Pittsburgh, PennsylvaniaAges 18–90
Hear when a new Urinary Bladder Neoplasms trial opens near Pittsburgh, PA
We’ll email you when one opens near Pittsburgh, PA — at most once a week, no account needed, unsubscribe anytime.
Urinary Bladder Neoplasms trials in other cities
Where these studies are running near Pittsburgh
Institutions with a site for the recruiting urinary bladder neoplasms studies listed above.
- Allegheny General Hospital
- Allegheny Health Network
- University of Pittsburgh Medical Center
- UPMC Hillman Cancer Center
What taking part in a urinary bladder neoplasms study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting urinary bladder neoplasms studies in Pennsylvania.
Common questions
- Are there urinary bladder neoplasms clinical trials near Pittsburgh?
- Yes. We're currently tracking 3 recruiting urinary bladder neoplasms studies with a site near Pittsburgh, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a urinary bladder neoplasms study near Pittsburgh?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Pittsburgh to take part?
- Not necessarily. These studies have a site near Pittsburgh, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a urinary bladder neoplasms trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New urinary bladder neoplasms studies open near Pittsburgh regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.